Renaissance Technologies LLC Sells 886,427 Shares of Oscar Health, Inc. (NYSE:OSCR)

Renaissance Technologies LLC cut its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 24.9% during the fourth quarter, HoldingsChannel.com reports. The fund owned 2,677,673 shares of the company’s stock after selling 886,427 shares during the quarter. Renaissance Technologies LLC’s holdings in Oscar Health were worth $35,988,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. KBC Group NV raised its holdings in shares of Oscar Health by 56.1% in the 4th quarter. KBC Group NV now owns 7,107 shares of the company’s stock valued at $96,000 after purchasing an additional 2,555 shares in the last quarter. ORG Wealth Partners LLC bought a new position in Oscar Health in the fourth quarter worth about $100,000. Alberta Investment Management Corp purchased a new stake in shares of Oscar Health during the fourth quarter valued at about $138,000. Virtu Financial LLC bought a new stake in shares of Oscar Health in the 4th quarter valued at about $140,000. Finally, Potentia Wealth purchased a new position in shares of Oscar Health in the 4th quarter worth approximately $141,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Up 2.8 %

Shares of OSCR stock opened at $12.59 on Friday. Oscar Health, Inc. has a fifty-two week low of $11.47 and a fifty-two week high of $23.79. The firm has a market capitalization of $3.15 billion, a PE ratio of -629.19 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock’s 50-day simple moving average is $14.02 and its 200-day simple moving average is $15.35.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Equities analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and cut their price target for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, three have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $20.21.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.